These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35367743)

  • 1. BauA and Omp34 surface loops trigger protective antibodies against Acinetobacter baumannii in a murine sepsis model.
    Akbari Z; Rasooli I; Ghaini MH; Chaudhuri S; Farshchi Andisi V; Jahangiri A; Ramezanalizadeh F; Schryvers AB
    Int Immunopharmacol; 2022 Jul; 108():108731. PubMed ID: 35367743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid antigens expressing surface loops of BauA from
    Chaudhuri S; Rasooli I; Oskouei RH; Pishgahi M; Jahangir A; Andisi VF; Schryvers AB
    Front Immunol; 2022; 13():933445. PubMed ID: 36045685
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of loop 3 of Omp34 from A. Baumannii in loopless C-lobe of TbpB of N. meningitidis.
    Golestani F; Malekan M; Rasooli I; Jahangiri A; Ramezanalizadeh F; Chaudhuri S; Farshchi Andisi V; Schryvers AB
    Int Immunopharmacol; 2022 Sep; 110():109013. PubMed ID: 35785727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-protein cocktail elicits a protective immune response against Acinetobacter baumannii in a murine infection model.
    Mirali M; Jahangiri A; Jalali Nadoushan M; Rasooli I
    Microb Pathog; 2023 Sep; 182():106262. PubMed ID: 37474079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Antigens Expressing Surface Loops of ZnuD From
    Qamsari MM; Rasooli I; Chaudhuri S; Astaneh SDA; Schryvers AB
    Front Immunol; 2020; 11():158. PubMed ID: 32117294
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model.
    Tamehri M; Rasooli I; Pishgahi M; Jahangiri A; Ramezanalizadeh F; Banisaeed Langroodi SR
    Microb Pathog; 2022 Dec; 173(Pt A):105874. PubMed ID: 36356792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model.
    Naghipour Erami A; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S
    Microb Pathog; 2021 Dec; 161(Pt B):105291. PubMed ID: 34798280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo validation of the immunogenicity of recombinant Baumannii Acinetobactin Utilization A protein (rBauA).
    Esmaeilkhani H; Rasooli I; Nazarian S; Sefid F
    Microb Pathog; 2016 Sep; 98():77-81. PubMed ID: 27374893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection.
    Aghajani Z; Rasooli I; Mousavi Gargari SL
    APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunoprotection against Acinetobacter baumannii infection: Synergistic effects of Bap and BauA in a murine model.
    Mansouri M; Sadeghpoor M; Jahangiri A; Ghaini MH; Rasooli I
    Immunol Lett; 2023 Oct; 262():18-26. PubMed ID: 37652189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective response against
    Ramezanalizadeh F; Rasooli I; Owlia P
    Future Microbiol; 2021 Feb; 16(3):143-157. PubMed ID: 33528272
    [No Abstract]   [Full Text] [Related]  

  • 12. Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii: An innovative approach.
    Jahangiri A; Rasooli I; Owlia P; Imani Fooladi AA; Salimian J
    J Microbiol Methods; 2018 Jan; 144():79-85. PubMed ID: 29133159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotectivity of Valine-glycine repeat protein G, a potent mediator of pathogenicity, against Acinetobacter baumannii.
    Pazoki M; Darvish Alipour Astaneh S; Ramezanalizadeh F; Jahangiri A; Rasooli I
    Mol Immunol; 2021 Jul; 135():276-284. PubMed ID: 33940514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprotective characterization of egg yolk immunoglobulin raised to loop 3 of outer membrane protein 34 (Omp34) in a murine model against Acinetobacter baumannii.
    Mesbahi Moghaddam M; Rasooli I; Ghaini MH; Jahangiri A; Ramezanalizadeh F; Ghasemkhah Tootkleh R
    Mol Immunol; 2022 Sep; 149():87-93. PubMed ID: 35785672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model.
    Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Naghipour Erami A; Darzi Eslam E; Darvish Alipour Astaneh S
    J Appl Microbiol; 2019 Feb; 126(2):624-632. PubMed ID: 30353977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive Roles of Two Acinetobactin Isomers in Challenging Host Nutritional Immunity.
    Kim M; Kim DY; Song WY; Park SE; Harrison SA; Chazin WJ; Oh MH; Kim HJ
    mBio; 2021 Oct; 12(5):e0224821. PubMed ID: 34517755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.
    Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Aghajani Z; Abdollahi S; Khalili S; Talei D; Eslam ED
    Sci Rep; 2021 Jan; 11(1):1914. PubMed ID: 33479293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.